Literature DB >> 7585047

Ribozymes in gene therapy.

J D Thompson1, D Macejak, L Couture, D T Stinchcomb.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7585047     DOI： 10.1038/nm0395-277

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  4 in total

1.  Comparison of the specificities and catalytic activities of hammerhead ribozymes and DNA enzymes with respect to the cleavage of BCR-ABL chimeric L6 (b2a2) mRNA.

Authors:  T Kuwabara; M Warashina; T Tanabe; K Tani; S Asano; K Taira
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

2.  Maximization of loading and stability of ssDNA:iron oxide nanoparticle complexes formed through electrostatic interaction.

Authors:  Lorenzo Berti; Temesgen Woldeyesus; Yuanpei Li; Kit S Lam
Journal:  Langmuir       Date:  2010-11-03       Impact factor: 3.882

3.  Inhibition of HPV-16 E6/E7 immortalization of normal keratinocytes by hairpin ribozymes.

Authors:  L M Alvarez-Salas; A E Cullinan; A Siwkowski; A Hampel; J A DiPaolo
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

4.  Ribozyme as an approach for growth suppression of human pancreatic cancer.

Authors:  H Kijima; K J Scanlon
Journal:  Mol Biotechnol       Date:  2000-01       Impact factor: 2.695
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.